Ono Pharmaceutical Co., Ltd. (OPHLY)

Ono Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 12, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	7,678	5,026	7,622	10,154	12,458	13,043
Market Cap Growth	57.23%	-34.06%	-24.93%	-18.50%	-4.48%	13.11%
Enterprise Value	7,298	4,953	7,043	9,448	12,065	12,357
Last Close Price	5.50	3.53	5.44	6.93	8.30	8.74
PE Ratio	19.29	15.04	9.01	11.97	18.79	19.13
PS Ratio	2.36	1.55	2.29	3.02	4.19	4.66
PB Ratio	1.42	0.96	1.44	1.81	2.29	2.25
P/TBV Ratio	2.69	1.75	1.57	2.01	2.56	2.55
P/FCF Ratio	10.09	9.77	10.81	8.75	26.86	21.54
P/OCF Ratio	9.58	9.13	10.42	8.46	24.47	19.50
EV/Sales Ratio	2.20	1.52	2.12	2.81	4.05	4.42
EV/EBITDA Ratio	10.07	8.36	5.97	7.50	11.40	11.93
EV/EBIT Ratio	15.06	12.00	6.65	8.37	13.22	13.84
EV/FCF Ratio	9.59	9.63	9.99	8.14	26.01	20.41
Debt / Equity Ratio	0.15	0.19	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	1.12	1.65	0.05	0.05	0.07	0.08
Debt / FCF Ratio	1.04	1.90	0.08	0.06	0.16	0.14
Asset Turnover	0.47	0.49	0.56	0.55	0.49	0.44
Inventory Turnover	2.14	2.40	2.72	2.54	2.31	2.38
Quick Ratio	2.36	2.32	2.92	1.71	2.56	1.58
Current Ratio	3.02	3.07	3.99	2.81	4.27	2.64
Return on Equity (ROE)	7.50%	6.32%	16.56%	16.02%	12.39%	12.49%
Return on Assets (ROA)	4.20%	3.91%	11.16%	11.57%	9.32%	8.69%
Return on Invested Capital (ROIC)	7.84%	7.64%	19.25%	18.70%	14.34%	13.52%
Return on Capital Employed (ROCE)	7.90%	6.70%	19.80%	19.80%	16.50%	15.10%
Earnings Yield	5.18%	6.65%	11.10%	8.35%	5.32%	5.23%
FCF Yield	9.91%	10.23%	9.25%	11.43%	3.72%	4.64%
Dividend Yield	9.75%	15.13%	9.72%	7.60%	5.55%	5.17%
Payout Ratio	59.97%	74.96%	29.05%	26.38%	34.36%	29.76%
Buyback Yield / Dilution	-0.02%	2.14%	1.70%	1.65%	0.54%	0.96%
Total Shareholder Return	9.73%	17.27%	11.43%	9.25%	6.09%	6.13%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.